Archive for the ‘Cholesterol’ Category
Friday, April 27th, 2007
Researchers report the first details of how cholesterol is metabolized without oxygen.
Cholesterol, a precursor to steroid hormones and a constituent of cell membranes, is usually broken down inside an organism in the presence of oxygen. The chemical reactions involved are well-known and have been used in industry ...
Posted in Cholesterol, Endocrinology | No Comments »
Friday, April 27th, 2007
Correcting social, economic and healthcare inequalities may have the most significant impact in reducing survival differences in colorectal cancer (CRC) between African Americans and Caucasians, according to a new study. Published in the June 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society, a meta-analysis of ...
Posted in Cholesterol, Public Health | No Comments »
Wednesday, April 25th, 2007
Pfizer announced that Lipitor (atorvastatin calcium) Tablets (80 mg) lowered hospitalization costs by significantly reducing the risk of cardiovascular events in patients with heart disease, according to two separate economic analyses. The data were presented at the annual meeting of the American College of Cardiology.
"One of these analyses suggests ...
Posted in Cardiovascular, Cholesterol, Statins | No Comments »
Wednesday, April 25th, 2007
Philanthropist and art collector Iris Cantor has made a major commitment to New York's Memorial Sloan-Kettering Cancer Center to create an endowed chair for a senior researcher in the field of digestive cancers. Mrs. Cantor is establishing the position with support totaling $2.5 million from the Iris and B. Gerald ...
Posted in Cancer / Oncology, Cholesterol, GastroIntestinal | No Comments »
Tuesday, April 24th, 2007
When it comes to cholesterol-lowering drugs, more is better. At least, that's what heart doctors and heart patients have been hearing in recent years. And as a result, more patients are taking higher doses of drugs called statins leading to lower heart and stroke risk, but higher prescription drug costs ...
Posted in Cardiovascular, Cholesterol, Clinical Trials / Drug Trials, Stroke / Neuroprotection | No Comments »
Monday, April 23rd, 2007
The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved ZETIA® (ezetimibe), a novel cholesterol-lowering agent that inhibits the absorption of cholesterol in the intestines. ZETIA® will be co-marketed by Bayer Yakuhin Ltd. and Schering-Plough K.K. Japan. The drug is approved for use either as monotherapy or co-administered with ...
Posted in Cholesterol, Clinical Trials / Drug Trials | No Comments »
Monday, April 23rd, 2007
Abbott submitted its New Drug Application to the Food and Drug Administration for a fixed-dose combination (Simcor) of Niaspan® (extended-release niacin) and simvastatin. This product seeks to target multiple lipid parameters in a single pill.
Niaspan and simvastatin are two widely prescribed medications for treating cholesterol. Niaspan is used to raise ...
Posted in Cholesterol, Clinical Trials / Drug Trials | No Comments »
Monday, April 23rd, 2007
A daily dose of adult-strength aspirin may modestly reduce cancer risk in populations with high rates of colorectal, prostate, and breast cancer if taken for at least five years.
The Women's Health Study trial recently reported that long-term use of low-dose aspirin (about 100mg every other day) does not reduce ...
Posted in Blood / Hematology, Cholesterol, Pain / Anesthetics, Prostate | No Comments »
Monday, April 23rd, 2007
Trials lasting 4 to 8 weeks indicate that including wholegrain oats in your diet may lower total and low-density lipoprotein cholesterol.
Coronary heart disease (CHD) is a major cause of death and ill health. One of the risk factors for CHD is elevated blood levels of total cholesterol and of ...
Posted in Cardiovascular, Cholesterol, Nutrition / Diet | No Comments »
